mitochondria
8 interactions related to mitochondria
simvastatin + coq10
Simvastatin blocks HMG-CoA reductase, the enzyme upstream of both cholesterol and coenzyme Q10 (CoQ10) synthesis, so it lowers circulating CoQ10 alongside cholesterol. This depletion is a plausible contributor to statin-associated muscle symptoms, and some randomized trials suggest CoQ10 supplements modestly ease those symptoms — though the evidence is mixed.
rosuvastatin + coq10
Rosuvastatin blocks HMG-CoA reductase, the enzyme that makes both cholesterol and coenzyme Q10, so it modestly lowers circulating CoQ10. The depletion is generally smaller than with fat-soluble statins, and mitochondrial impairment is only one proposed mechanism for statin-associated muscle symptoms. This is a possible-benefit pairing, not a dangerous one.
acetyl-l-carnitine + alpha-lipoic acid
Acetyl-L-carnitine shuttles fatty acids into mitochondria for energy production while alpha-lipoic acid acts as a mitochondrial antioxidant and cofactor for energy-producing enzymes. In aged-animal studies the combination reversed markers of mitochondrial decay and improved memory more than either alone; strong direct evidence in humans is still limited.
coq10 + pqq
CoQ10 carries electrons in the mitochondrial electron transport chain to help produce ATP, while PQQ signals the cell to build new mitochondria via PGC-1alpha. Used together they support both the efficiency and the number of energy-producing mitochondria. The combination is well tolerated, with modest human evidence for cognitive and fatigue benefits.
niacin + coq10
Niacin (vitamin B3) is the precursor to NAD+ and NADH, the electron carriers that feed Complex I of the mitochondrial electron transport chain, where CoQ10 shuttles those electrons onward toward ATP synthesis. They support adjacent steps of the same energy-producing pathway, making them a plausible mitochondrial-support pairing. The combination has not been tested head-to-head in humans, so the benefit is biologically reasonable rather than proven.
atorvastatin + coq10
Atorvastatin inhibits HMG-CoA reductase, the upstream enzyme also needed to make coenzyme Q10 (ubiquinone), so statin therapy lowers blood CoQ10 levels. Mitochondrial CoQ10 depletion is one proposed mechanism for statin-associated muscle symptoms, but evidence that taking CoQ10 reverses those symptoms is modest and mixed. This is a supplement-may-help question, not a harmful interaction.
nad+ + niacin
Niacin (nicotinic acid) is a vitamin B3 form the body converts to NAD+ through the Preiss-Handler pathway, so pairing low, vitamin-level niacin with a direct NAD+ precursor gives cells more than one biosynthetic route to build their NAD+ pool. Niacin has been shown to raise muscle and blood NAD+ in mitochondrial myopathy, though no human trial has tested combining it with direct NAD+, NR, or NMN — the synergy is plausible additive biology rather than a proven stack.
acetyl-l-carnitine + coq10
Acetyl-L-carnitine (ALCAR) helps shuttle long-chain fatty acids into mitochondria for beta-oxidation, and CoQ10 carries the resulting electrons through the respiratory chain. The two act at complementary steps of mitochondrial energy production. The human trials people cite for this pairing actually test multi-nutrient cocktails (with alpha-lipoic acid and B vitamins), not ALCAR plus CoQ10 alone, so any combined benefit in healthy people is likely subtle. Both ingredients have a long safety record and no clinically important interaction with each other.